what happened to acadia stock

by Prof. Elwyn Raynor Published 3 years ago Updated 2 years ago

Shares of the mid-cap biopharma Acadia Pharmaceuticals (NASDAQ: ACAD) fell by as much as 44% in pre-market trading Tuesday morning. The drugmaker's stock is crashing today in response to a regulatory setback for pimavanserin's proposed label expansion as a treatment for dementia-related psychosis.

Full Answer

See more

Get the latest ACADIA Pharmaceuticals Inc. (ACAD) stock news and headlines to help you in your trading and investing decisions.

Why did Acadia stock fall?

Acadia Pharmaceuticals (ACAD) will ask the Food and Drug Administration to approve a once-rejected psychosis drug, but ACAD stock plunged on Tuesday. The FDA previously rejected Acadia's Nuplazid as a treatment for dementia-related psychosis.Dec 21, 2021

Is Acadia a good stock to buy now?

ACADIA Pharmaceuticals Inc.

finds support from accumulated volume at $22.45 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested. This stock has average movements during the day and with good trading volume, the risk is considered to be medium.

Will Acadia Pharmaceuticals stock go up?

Stock Price Forecast

The 18 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 31.00, with a high estimate of 37.00 and a low estimate of 20.00. The median estimate represents a +83.98% increase from the last price of 16.85.

Is ACAD a good investment?

The financial health and growth prospects of ACAD, demonstrate its potential to underperform the market. It currently has a Growth Score of A. Recent price changes and earnings estimate revisions indicate this would not be a good stock for momentum investors with a Momentum Score of D.

Is Acadia a good company?

Acadia Pharmaceuticals is ranked #100 on the Best Health Care Companies to Work For in California list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.Dec 14, 2021

What does Acadia Pharmaceuticals make?

ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders.

ACADIA Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ACADIA Pharmaceuticals (NASDAQ ACAD) News Headlines Today

Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm.

Stock FAQs